Free shipping on orders over $99
Elsevier's 2025 Intravenous Medications

Elsevier's 2025 Intravenous Medications

A Handbook for Nurses and Health Professionals

by Shelly Rainforth Collins
Spiral bound
Publication Date: 20/09/2024

Share This Book:

RRP  $85.95

RRP means 'Recommended Retail Price' and is the price our supplier recommends to retailers that the product be offered for sale. It does not necessarily mean the product has been offered or sold at the RRP by us or anyone else.

$81.75
or 4 easy payments of $20.44 with
afterpay
    Please Note: We will source your item through a special order. Generally sent within 120 days.
**Selected for Doody's Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
  • Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference.
  • Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
  • Additional drug monographs are provided on the Evolve website.
  • Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks.
  • Blue-screened text calls attention to special circumstances not covered by Black Box Warnings.
  • Dosage and dilution charts within monographs provide quick summaries of essential clinical information.
  • Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
  • Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
  • Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
  • NEW! Drug monographs for 16 newly approved drugs by the FDA include the most current information.
  • NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.
  • NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety.
ISBN:
9780443120404
9780443120404
Category:
Pharmacology
Format:
Spiral bound
Publication Date:
20-09-2024
Language:
English
Publisher:
Elsevier
Country of origin:
United Kingdom
Edition:
41st Edition
Dimensions (mm):
228.6x152.4mm

Our Australian supplier has this title on order. You can place a backorder for this title now and we will ship it to you when it becomes available. 

While we are unable to provide a delivery estimate, most backorders will be delivered within 120 days. If we are informed by our supplier that the title is no longer available during this time, we will cancel and refund you for this item.  Likewise, if no delivery estimate has been provided within 120 days, we will contact our supplier for an update.  If there is still no delivery estimate we will then cancel the item and provided you with a refund.

If we are able to secure you a copy of the title, our supplier will despatch it to our Sydney warehouse.  Once received we make sure it is in perfect condition and then despatch it to you via the Australia Post eParcel service, which includes online tracking.  You will receive a shipping notice from us when this occurs.

Reviews

Be the first to review Elsevier's 2025 Intravenous Medications.